Underweight with 25-30% trim at $1,066; retain 70-75% core; $1,018 hard stop
The 9/21 lesson is dispositive: Hold in this exact configuration (MACD widening, price below all MAs, beta 1.43, post-200-SMA-test) lost -2.2% alpha. The unanimous analyst Hold consensus is methodologically blind to this meta-evidence. A 25-30% trim formalizes Underweight while retaining 70-75% core for franchise participation. Stop at $1,018; re-engagement triggers pre-committed at $1,103 reclaim or confirmed MACD-H divergence. The franchise floor (PEG 0.91, forward P/E 16.6x, $7.58B FCF, 35.1% operating margins, $11T+ AUM) prevents a full Sell—this is tactical risk management, not thesis change.
| Position | Action |
|---|---|
| Default position | Trim 25-30% at $1,066; retain 70-75% core for franchise participation through Q3 earnings |
| Confirmed close below $1,018 on volume >1.5M | Additional 15% trim and likely downgrade to Sell |
| Optional for hedgers | Collar: Long $1,050 puts / Short $1,146 calls through November OPEX (costless if priced at current IV) |
The 9% pullback from $1,176 to $1,066 is a buyable dip within a structurally intact secular uptrend, supported by accelerating fundamentals (revenue +30.6% YoY, 35.1% operating margin, $7.58B FCF), record inflows into flagship products, and a macro backdrop (8% recession odds, Fed in hiking cycle, 96% odds of no cuts) that favors BLK's product mix.
| Indicator | Value | Signal |
|---|---|---|
| Close | 1066.66 | neutral |
| 10-EMA | 1074.89 | bearish |
| 50-SMA | 1103.63 | bearish |
| 200-SMA | 1050.68 | bullish |
| RSI (14) | 43.38 | bearish |
| MACD Line | -14.84 | bearish |
| MACD Signal | -10.98 | bearish |
| MACD-Histogram | -3.86 | bearish |
| Bollinger Middle (20-SMA) | 1101.00 | bearish |
| Bollinger Upper Band | 1185.70 | neutral |
| Bollinger Lower Band |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: MACD-H forms higher low while price prints lower low, with RSI also diverging
Then: Re-add 25-30% of trimmed position
MACD-H at -3.86 represents mean-reversion setup, not bearish escalation — MACD-H peaked at +6.70 in early August and has been working off overbought conditions from $1,176 high, indicating a digestion phase within an uptrend.
↩ rebuts: “Bear's interpretation of MACD-H as bearish escalation”
EV: +7–10% on a 1–3 month horizon to $1,146 near-term, $1,185+ on a clean 10-EMA reclaim · concedes: MACD-H trough-deepening is true today but is a lagging indicator within compressed ATR — bullish divergence setup is approaching; 200-SMA break to $1,016 is the bear trigger, but $1,016-$1,018 is triple-confluence support with aggressive buying expected; Trailing P/E of 25.5x appears premium but forward P/E of 16.6x with ~54% EPS expansion makes it a forward discount; Beta of 1.43 means bigger drawdowns in a 2008-style collapse, but current setup has 8% recession odds, Fed hiking cycle, and $1.4B weekly buyback+dividend support cushioning downside
The tape is rolling over for BLK: 200-SMA support is a level under siege on a high-beta stock, technicals confirm a medium-term reversal, revenue growth is acquisition-optical with negative FCF in Q1, and "higher-for-longer" macro is a headwind that compresses equity AUM—the bear case is built on what the market is actually doing, not what the narrative promises.
EV: -$942 to -$909 (12-15% downside on second leg) · concedes: Bull case is polished and cites the right numbers; Q2 revenue growth (30.6% YoY) is the bull's strongest card; Consensus $64.31 forward EPS represents 20% growth even if overoptimistic; Institutional flows are stickier than retail (conditional on market stability); Q2 FCF of $1.118B did show rebound from Q1 disruption
→ vs conservative: The 200-SMA at $1,050.68 is not a cliff edge but a rising support line; $16 of cushion above a rising 200-day with $7.58 billion in trailing FCF and 35% operating margins does not constitute a stop-out moment
→ vs conservative: Bearish technicals are a lagging story; the fundamentals show no breakdown—PEG at 0.91 and forward P/E of 16.6 against S&P 19 is not a stock to flee from but accumulate through weakness
→ vs neutral: Waiting for confirmation is implicitly bearish due to beta decay and opportunity cost; every catalyst the neutral analyst wants—Fed regime shift, record muni ETF inflows, Bitcoin breaking $86,000, IBIT $1 billion single-day flows—is already here converging simultaneously
→ vs neutral: The QQQ challenger launch is not fee compression but a market share grab against the most lucrative tech ETF vehicle backed by superior iShares distribution
| 1016.31 |
| bullish |
| ATR (14) | 24.82 | neutral |
| VWMA (~20-day) | 1078.04 | bearish |
Support: 1050.68 · 1016.31 | Resistance: 1074.89 · 1103.63 · 1146 · 1185.7
BLK presents a classic "wait-and-see" setup with short-term momentum bearish (MACD below zero since 9/9, MACD-H still deepening at -3.86) but long-term structure intact (200-SMA rising and only $16 below close). The $1,016-$1,018 zone represents a high-confluence support area where the Bollinger Lower Band ($1,016.31) aligns with 2×ATR from current close. Bears have the near-term edge, but capitulation-style washouts from earlier 2026 lows (~$909, $942) are not yet visible, suggesting this remains a correction within an intact secular uptrend. A daily close above the 10-EMA ($1,074.89) would signal the first short-term reversal, while a 200-SMA breach would open the $1,016-$1,018 support zone.
Market Cap
$173.31B
P/E Ratio (TTM)
25.54x
Forward P/E
16.59x
PEG Ratio
0.91
Price/Book
2.87x
Dividend Yield
2.10%
Revenue (TTM)
$27.30B
EBITDA
$11.12B
Net Income
$6.58B
Operating Margin
35.08%
Net Profit Margin
24.09%
ROE
12.28%
ROA
3.74%
EPS (TTM)
$41.76
Forward EPS
$64.31
Implied EPS Growth
~54%
Total Assets
$175.88B
Total Equity
$57.61B
Long-Term Debt
$12.74B
Current Ratio
2.45
Goodwill
$35.20B
Free Cash Flow (TTM)
$7.58B
Q2 2026 FCF
$1.118B
Dividends Paid (Q2 2026)
$933M
Buybacks (Q2 2026)
$461M
Beta
1.429
Book Value per Share
$371.70
52-Week High
$1,219.94
52-Week Low
$917.39
200-Day Average
$1,061.41
Q2 2026 Total Revenue
$7.084B
Q2 2026 Gross Profit
$3.468B
Q2 2026 Operating Income
$2.472B
Q2 2026 Diluted EPS
$12.19
Q2 2026 EBITDA
$3.238B
Cash & Equivalents
$10.49B
Goodwill & Intangibles
$62.62B
Debt-to-Equity
23.19
Strengths
Concerns
BlackRock demonstrated strong Q2 2026 performance with $7.08B in revenue (up 30.6% YoY) driven by organic growth and the GIP acquisition, maintaining industry-leading 35.1% operating margins while generating $7.58B in TTM free cash flow. The company trades at 25.5x P/E with a 16.6x forward P/E and 0.91 PEG ratio suggesting ~54% expected EPS growth, supported by secular tailwinds in passive investing, private markets, and ETF growth. Key risks include market sensitivity (beta 1.43), negative tangible book value, and $35.2B goodwill impairment exposure, though the robust capital return program ($1.4B in Q2 2026 dividends and buybacks) and strong liquidity (current ratio 2.45) provide downside support.
Macro: Federal Reserve raised interest rates for the first time since 2023, with prediction markets pricing 96% probability of no Fed cuts in 2026. US recession odds collapsed to 8% (down 11.5pp WoW), while UK and Japan recession odds at 4% each. Bond rout driving record muni ETF inflows and favoring active fixed-income management. Higher-for-longer + soft-landing environment broadly constructive for BlackRock's product mix.